Sulfonylureas as second line treatment for type 2 diabetes
- PMID: 30021790
- DOI: 10.1136/bmj.k3041
Sulfonylureas as second line treatment for type 2 diabetes
Conflict of interest statement
Competing interests: We have read and understood the BMJ policy on declaration of interests and declare: none.
Comment on
-
Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study.BMJ. 2018 Jul 18;362:k2693. doi: 10.1136/bmj.k2693. BMJ. 2018. PMID: 30021781 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical